Literature DB >> 8347165

Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels and cell survival.

B Fromenty1, P Letteron, C Fisch, A Berson, D Deschamps, D Pessayre.   

Abstract

Human lymphocytes were assessed as a cellular model for determining the effects of drugs on human mitochondria. Formation of total oxidized 14C-products was maximal with 1 mM [U-14C]palmitic acid, was linear for 90 min, linear with the number of lymphocytes, and decreased by 95% and 77% in the presence of 30 microM rotenone and 2 mM KCN. Seven drugs were tested which had previously been shown to inhibit beta-oxidation in animals; all decreased formation of total oxidized 14C-products by human lymphocytes, but with different IC50 values: 35 microM with amiodarone, 2.75 mM with tetracycline and amineptine, 3.75 mM with tianeptine, and more than 10 mM for valproic acid and the ibuprofen enantiomers. Formation of [14C]CO2 either increased or decreased, in relation to the various effects of these drugs on coupling, beta-oxidation, and the tricarboxylic acid cycle. There was a general trend for some relationship between inhibition of fatty acid oxidation and loss of cellular ATP. Those compounds, however, which uncoupled oxidative phosphorylation (2,4-dinitrophenol, amiodarone, ibuprofen) and/or inhibited the mitochondrial respiratory chain (amiodarone, rotenone, KCN) resulted in comparatively higher ATP depletion. Amiodarone, a drug which produces several effects (uncoupling, inhibition of beta-oxidation, of the tricarboxylic acid cycle and of the respiratory chain), caused a dramatic decrease in cellular ATP and cell viability at low concentrations (20-100 microM). Both these effects were prevented by the addition of 5 mM glucose, a substrate for anaerobic glycolysis. We conclude that human lymphocytes may be a useful model for assessing the effects of drugs on human mitochondrial function. IC50 values determined with this model may not necessarily apply, however, to other cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347165     DOI: 10.1016/0006-2952(93)90518-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.

Authors:  Reine Note; Caroline Maisonneuve; Philippe Lettéron; Gilles Peytavin; Fatima Djouadi; Anissa Igoudjil; Marie-Christine Guimont; Michel Biour; Dominique Pessayre; Bernard Fromenty
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  Oxidative phosphorylation in intact hepatocytes: quantitative characterization of the mechanisms of change in efficiency and cellular consequences.

Authors:  X Leverve; B Sibille; A Devin; M A Piquet; P Espié; M Rigoulet
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

3.  Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity.

Authors:  Alina M Bețiu; Imen Chamkha; Ellen Gustafsson; Elna Meijer; Vlad F Avram; Eleonor Åsander Frostner; Johannes K Ehinger; Lucian Petrescu; Danina M Muntean; Eskil Elmér
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

4.  Amiodarone Alters Cholesterol Biosynthesis through Tissue-Dependent Inhibition of Emopamil Binding Protein and Dehydrocholesterol Reductase 24.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Allison Anderson; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  ACS Chem Neurosci       Date:  2020-04-29       Impact factor: 4.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.